Brett Matthew Hall, Chief Scientific Officer at Immuneering Corp (IMRX), bought 6,393 shares at $15.00 ($20K) on 2021-08-03, disclosed to the SEC on 2021-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,040 | $0 | 0.0% |
| 2 | $15.00 | 1,353 | $20K | 100.0% |
| Total | $3.17 avg | 6,393 | $20K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-24 | $35K | — | Filing → |
| IMRX | BUY | 2024-03-21 | $20K | — | Filing → |
| IMRX | BUY | 2022-05-27 | $10K | — | Filing → |